NASDAQ · Medical - Healthcare Information Services

Omnicell, Inc. (OMCL) Stock

$34.83 -1.08% NASDAQ: OMCL Healthcare

Valuation

MetricValue
Price$34.83
Market Cap$1.58B
P/E Ratio39.83
P/B Ratio1.20
P/S Ratio1.24
EPS (TTM)$0.44
52-Week High$55.00
52-Week Low$29.06
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE3.13%
ROA1.96%
ROCE3.80%
Gross Margin43.87%
Operating Margin5.44%
Net Margin3.13%
Debt/Equity0.15
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.1B$1.3B$1.1B$1.1B$1.2B
Operating Profit$90.0M$-2.0M$-19.0M$0$12.0M
Net Profit$78.0M$6.0M$-20.0M$13.0M$2.0M
EPS$1.62$0.12$-0.45$0.27$0.04
Op Margin7.9%-0.2%-1.7%0.0%1.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.1B$2.2B$2.2B$2.1B$2.0B
Total Liabilities$996.0M$1.1B$1.0B$878.0M$743.0M
Cash$349.0M$330.0M$468.0M$369.0M$197.0M
Borrowings$541.0M$617.0M$614.0M$383.0M$204.0M

Latest News

2 Cash-Heavy Stocks to Target This Week and 1 We Turn Down StockStory · Jul 22, 2026 OMCL: Lowering target price to $44.00 Argus Research · Jul 22, 2026 Omnicell to Report Q2 Earnings: OmniSphere in Focus Zacks · Jul 21, 2026 1 Healthcare Stock to Target This Week and 2 We Brush Off StockStory · Jul 20, 2026 The Bull Case For Omnicell (OMCL) Could Change Following New President And ESOP Share Offering Simply Wall St. · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$232.0M$78.0M$181.0M$188.0M$127.0M
Investing Cash Flow$-441.0M$-119.0M$-96.0M$-89.0M$-101.0M
Financing Cash Flow$47.0M$-61.0M$3.0M$-49.0M$-60.0M
Net Cash Flow$-134.0M$-3.0M$148.0M$-102.0M$-148.0M
Free Cash Flow$203.0M$17.0M$140.0M$151.0M$87.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.57
EV / EBITDA13.73
FCF Yield9.13%
Quick Ratio1.43
Interest Coverage14.93
Return 1Y39.54%
Return 3Y-36.75%
Return 5Y-74.00%

Ownership

Insiders Held2.25%
Institutions Held105.83%
Institutions Float Held108.26%
Institutional HolderSharesReport Date
Blackrock Inc.7,207,2182026-03-31
Vanguard Portfolio Management LLC3,214,7662026-03-31
Wellington Management Group, LLP2,707,0462026-03-31
Dimensional Fund Advisors LP2,450,3852026-03-31
Millennium Management Llc2,288,5702026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About Omnicell, Inc.

Omnicell, Inc. (OMCL) stock trades at $34.83 with a market capitalization of $1.58B. The stock is valued at a price-to-earnings (P/E) ratio of 39.83, price-to-book of 1.20, price-to-sales of 1.24. Over the past 52 weeks the stock has ranged between $29.06 and $55.00, and currently trades 36.7% below its 52-week high.

On profitability, Omnicell, Inc. generates a return on equity (ROE) of 3.13%, return on capital employed of 3.80%, an operating margin of 5.44%, a net profit margin of 3.13%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides